Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07052422
What this trial is testing

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Who this might be right for
Older PatientsMyeloid MalignanciesConditioning+1 more
Nanfang Hospital, Southern Medical University 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT05941897
What this trial is testing

Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy

Who this might be right for
Advanced or Metastatic NSCLC
AstraZeneca 39
Not applicableStudy completedNCT01893268
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 279
Not applicableEnded earlyNCT02063113
What this trial is testing

Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.

Who this might be right for
Multiple Myeloma in Older Patients
Nantes University Hospital 48
Large-scale testing (Phase 3)Looking for participantsNCT07396480
What this trial is testing

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

Who this might be right for
VenentoclaxMyeloid MalignanciesConditioning+3 more
First Affiliated Hospital of Zhejiang University 186
Post-approval studies (Phase 4)Study completedNCT02532569
What this trial is testing

Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj

Who this might be right for
Japanese Encephalitis
Boryung Pharmaceutical Co., Ltd 94
Not applicableWithdrawnNCT01671813
What this trial is testing

Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00005059
What this trial is testing

Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 51
Testing effectiveness (Phase 2)Study completedNCT00075374
What this trial is testing

Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01404741
What this trial is testing

5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
Universitätsklinikum Hamburg-Eppendorf 191
Early research (Phase 1)Study completedNCT01683682
What this trial is testing

An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Aktion Bronchialkarzinom e.V. 8
Not applicableStudy completedNCT03457870
What this trial is testing

Intermittent Energy Restriction and Chewing on Neural Stem Cell Ageing and Adult Hippocampal Neurogenesis Associated Cognition

Who this might be right for
AgingCognitive Decline
King's College London 123
Testing effectiveness (Phase 2)Study completedNCT01242566
What this trial is testing

Temozolomide in Elderly Patients With KPS < 70

Who this might be right for
Primary Brain TumorGlioblastoma
Assistance Publique - Hôpitaux de Paris 70
Testing effectiveness (Phase 2)UnknownNCT01221103
What this trial is testing

Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)

Who this might be right for
Lymphoma, Mantle-Cell
Southern Europe New Drug Organization 50
Testing effectiveness (Phase 2)Study completedNCT00027872
What this trial is testing

Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more
National Cancer Institute (NCI) 125
Not applicableEnded earlyNCT02519712
What this trial is testing

Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

Who this might be right for
Acute Myeloid Leukemia (AML)
Memorial Sloan Kettering Cancer Center 4
Post-approval studies (Phase 4)Study completedNCT03020498
What this trial is testing

B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

Who this might be right for
Influenza
Stanford University 91
Testing effectiveness (Phase 2)Study completedNCT01190787
What this trial is testing

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 150
Early research (Phase 1)Ended earlyNCT05660265
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

Who this might be right for
Hematologic DiseasesAnaemia, Sickle Cell
GlaxoSmithKline 11
Large-scale testing (Phase 3)Study completedNCT00441922
What this trial is testing

Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 166
Next Page